|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Commissions and other agent-related costs | |||||
| Gross profit | |||||
| Operating expenses | |||||
| General and administrative expenses | |||||
| Technology and development expenses | |||||
| Sales and marketing expenses | |||||
| Impairment expense | |||||
| Litigation contingency | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Other (income) expense | |||||
| Other (income) expense, net | |||||
| Equity in (income) losses of unconsolidated affiliates | |||||
| Income (loss) before income tax expense | |||||
| Income tax (benefit) expense | |||||
| Net income (loss) from continuing operations | |||||
| Net income (loss) from discontinued operations | |||||
| Net income (loss) | |||||
| Basic, net income (loss) from continuing operations (in dollars per share) | |||||
| Basic, net income (loss) from discontinued operations (in dollars per share) | |||||
| Basic, net income (loss) (in dollars per share) | |||||
| Diluted, net income (loss) from continuing operations (in dollars per share) | |||||
| Diluted, net income (loss) from discontinued operations (in dollars per share) | |||||
| Diluted, net income (loss) (in dollars per share) | |||||
| Weighted average shares outstanding - Basic | |||||
| Weighted average shares outstanding - Diluted | |||||
| Comprehensive income (loss): | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation gain (loss), net of tax | |||||
| Comprehensive income (loss) | |||||
Loading...